Articles

It was once thought that after guiding the development of male sex organs in a fetus, the Y chromosome did not do much else. But over the past few years, results from multiple studies have challenged that belief. Read More ›

Cancer researchers continue to make progress in developing tests using liquid biopsies that could complement and even serve as an alternative to traditional tissue biopsies. Read More ›

Opioids such as morphine are the gold standard for treating cancer-induced bone pain, but new University of Arizona Health Sciences research recently published in PAIN uncovered a mechanism by which chronic morphine use may increase bone loss and pain. Read More ›

I am pleased to present the August issue of The Oncology Nurse-APN/ PA, a journal specifically designed for nurses, navigators, and advanced practice providers who work tirelessly to improve the lives of patients with cancer. Read More ›

Hunterdon Regional Cancer Center, Flemington, NJ, is a community-based cancer center offering an integrative approach to care, with access to prevention initiatives and screening as well as comprehensive diagnosis and treatment. Read More ›

Cancers and tumors of the appendix are extremely rare, with an estimated incidence of 0.15 to 0.9 per 100,000 people. The average age of onset is between 50 and 55 years, and the disease appears to affect men and women equally. Evidence suggests that the incidence of appendix cancer has increased over the past 2 decades. Read More ›

This section provides a brief overview of new cancer drugs and new indications approved by the FDA between May 19, 2023, and June 20, 2023. Read More ›

Chicago, IL—Interim results from the phase 3 COMMANDS trial demonstrated that first-line treatment with luspatercept-aamt (Reblozyl) increased hemoglobin levels and enabled nearly twice as many patients with transfusion-dependent, lower-risk myelodysplastic syndromes (MDS) to avoid red blood cell transfusions during the first 24 weeks of the study compared with standard-of-care epoetin alfa. Read More ›

Chicago, IL—The presidential theme for the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting was “Partnering With Patients: The Cornerstone of Clinical Care and Research.” In his address during the opening session of the meeting, Eric P. Winer, MD, FASCO, ASCO’s 2022-2023 President, discussed the importance of physician–patient partnerships for improving healthcare outcomes. Read More ›